Pharma Foods International Co Ltd
TSE:2929
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
808
1 180
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Pharma Foods International Co Ltd
Net Income
Pharma Foods International Co Ltd
Net Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Pharma Foods International Co Ltd
TSE:2929
|
Net Income
ÂĄ5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
50%
|
CAGR 10-Years
83%
|
||
GNI Group Ltd
TSE:2160
|
Net Income
ÂĄ8B
|
CAGR 3-Years
59%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
||
PeptiDream Inc
TSE:4587
|
Net Income
ÂĄ24B
|
CAGR 3-Years
39%
|
CAGR 5-Years
47%
|
CAGR 10-Years
63%
|
||
Takara Bio Inc
TSE:4974
|
Net Income
ÂĄ1.7B
|
CAGR 3-Years
-59%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-3%
|
||
S
|
StemRIM Inc
TSE:4599
|
Net Income
-ÂĄ2B
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
C
|
Cuorips Inc
TSE:4894
|
Net Income
-ÂĄ630m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Pharma Foods International Co Ltd
Glance View
Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.
See Also
What is Pharma Foods International Co Ltd's Net Income?
Net Income
5B
JPY
Based on the financial report for Oct 31, 2024, Pharma Foods International Co Ltd's Net Income amounts to 5B JPY.
What is Pharma Foods International Co Ltd's Net Income growth rate?
Net Income CAGR 10Y
83%
Over the last year, the Net Income growth was 42%. The average annual Net Income growth rates for Pharma Foods International Co Ltd have been -4% over the past three years , 50% over the past five years , and 83% over the past ten years .